Home > Covid-19 Vaccine

UK MHRA Grants CMA to Inactivated Covid-19 Vaccine of Valneva

The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted the Conditional Marketing Authorization (CMA) to the inactivated covid-19 vaccine candidate ‘VLA2001’ developed by Valneva in the adults aged between 18 to 50 years. The novel corona virus vaccine of Valneva has been indicated for the initial

Read More